A Contralateral Esophagus Sparing Technique to Limit Severe Esophagitis Associated With Concurrent Chemoradiation Therapy in Lung Cancer Patients

Acute esophagitis is a dose limiting side effect in patients undergoing concurrent chemoradiation therapy (CRT) for lung cancer. Severe (Radiation Therapy Oncology Group [RTOG] Grade 3 or greater) esophagitis generally occurs in 15-20% of non-small cell lung cancer (NSCLC) patients, which may result in treatment breaks that compromise local tumor control and poses a barrier to dose escalation > 66 Gy. Here, we report a novel contralateral...